LZ
Lonza Group AG
LZAGY · OTC
$67.07 +1.16% (+$0.77)
1M -9.46%
Market Cap CHF 39.2B
P/E Ratio 41.28x
Div. Yield 0.85%
ROE 10.78%
Bulios Fair Price
$37.71
43.8% downside
Trenutna cena
$67.07
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LZAGY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
23 /100
Expensive P/S 6.00x
P/E 41.28x
P/B 4.29x
Growth
14 /100
Declining Book val. growth 4.83%
EPS growth 6.09%
Rev. growth 1.62%
Profitability
56 /100
Moderate Op. margin 20.21%
Gross margin 35.35%
FCF margin 2.98%
Quality
41 /100
Average ROA 5.00%
ROIC 6.87%
Asset turnover 0.34x
Debt
73 /100
Low Int. coverage 7.80x
Debt/Equity 0.46x
Net debt/EBITDA 2.65x
Stability
82 /100
Stable EPS volatility 48.58%
Beta 0.84x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LZAGY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Wolfgang Wienand
Employees
16,866
Headquarters
Basel